Stocks to buy: Choice Broking sees 20% upside in this healthcare stock. Should you buy?
Choice's forecast indicates significant earnings growth for Park Medi World, expecting revenue to rise from ₹16.8 billion in FY26 to ₹39.4 billion by FY29, with stable EBITDA margins of 26.5%. The brokerage maintains a 'BUY' rating and sets a target price of ₹350.
What's Your Reaction?
Like
0
Dislike
0
Love
0
Funny
0
Wow
0
Sad
0
Angry
0
Comments (0)